Role of D-type cyclins in heart development and disease

Author： Robinson Jessica   MacLean Jessica   Feridooni Tiam   Wafa Karim   Pasumarthi Kishore B.S.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.90, Iss.9, 2012-09, pp. : 1197-1207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H.   Kennedy F.P.   Garratt K.N.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Combined Type 2 Diabetes and Ischemic Heart Disease: Double Jeopardy

By  

Heart Drug, Vol. 1, Iss. 3, 2001-07 ,pp. : 129-131

Karger

Access to resources Recommend Favorite

The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease

By  

Current Medicinal Chemistry, Vol. 16, Iss. 26, 2009-09 ,pp. : 3341-3358

Bentham Science Publishers

Access to resources Recommend Favorite

Type I IFNs and their role in the development of autoimmune diseases

By Burdick Laura M   Somani Najwa   Somani Ally-Khan  

Expert Opinion on Drug Safety, Vol. 8, Iss. 4, 2009-07 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 933-942

Bentham Science Publishers

Access to resources Recommend Favorite